← Open Payments lookup

DIEDRA THIES: Open Payments

NPI 1790135481 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$710 in 38 payments from 19 companies in 2025. Trend: 2023 $769 · 2024 $471 · 2025 $710

Food & beverage: $710
CompanyPaymentsAmount
ABBVIE INC.7$161
Otsuka America Pharmaceutical, Inc.8$142
AstraZeneca Pharmaceuticals LP5$82
Lundbeck LLC2$32
Astellas Pharma US Inc1$28
Amgen Inc.2$28
Medtronic, Inc.1$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
BioMarin Pharmaceutical Inc.1$22
Supernus Pharmaceuticals, Inc.1$21

Products named: REXULTI, QULIPTA, UBRELVY, VRAYLAR, Veozah, EVENITY, SYMPLICITY G3, CAPLYTA.

Industry payments across NE — which companies pay providers there.